Deals

HPE conf
Biotech

US biotechs thinking twice about licensing drugs to Europe

U.S. biotechs are increasingly reluctant to license their drugs to European partners in order to avoid becoming a target of the Trump administration.
James Waldron Sep 26, 2025 8:09am
research deal two people shaking hands in lab

Merck opts in on Evaxian's preclinical vaccine candidate

Sep 25, 2025 7:00am
increase

Biopharma biobucks decline, while upfront deal payments rise

Sep 24, 2025 11:30am
3D Rendering futuristic robot technology development artificial intelligence

Merck inks $349M biobucks deal to apply AI to tricky targets

Sep 23, 2025 7:00am
human brain abstract art

Angelini signs $550M-plus neuro pact with South Korean biotech

Sep 22, 2025 1:47pm
Measuring tape on top of cash

Pfizer inks $4.9B Metsera buyout to beef up obesity pipeline

Sep 22, 2025 7:47am